Krebs Biochemicals & Industries Ltd
NSE: KREBSBIO BSE: 524518
₹57.04
(-4.65%)
Wed, 04 Mar 2026, 11:11 pm
Market Cap1.25B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KKrebs Biochemicals & Industries Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 284.86M | 472.89M | 494.16M | 501.38M | 442.29M | 705.40M | 712.44M | 138.26M | 0 | 12.54M | 20.21M | 327.27M | 467.41M | 323.95M | 526.84M | 605.01M | 525.34M | 504.21M | 433.12M |
| Gross profit | -75.22M | 19.17M | -7.36M | -366.09M | -27.02M | -46.23M | -77.04M | -101.61M | -92.70M | -135.35M | -105.30M | -88.19M | -109.73M | -197.52M | -199.78M | -332.75M | -172.07M | -80.63M | -118.72M |
| Operating expenses (excl. COGS) | -7.61M | -5.59M | -7.61M | -9.41M | -30.26M | -47.68M | -33.45M | -21.74M | -42.77M | -33.30M | -28.94M | -38.95M | -42.59M | -43.44M | -36.87M | -62.19M | -47.32M | -74.27M | -98.47M |
| Selling/general/admin expenses, total | — | — | — | — | -28.76M | -45.88M | -32.37M | -14.89M | -39.15M | -22.77M | -25.45M | -35.65M | -38.33M | -32.00M | -32.87M | -47.51M | -41.66M | -68.40M | -93.54M |
| Research & development | -2.61M | -1.13M | -1.25M | -1.61M | -696.96K | -6.74M | -8.30M | -2.02M | 0 | — | -553.00K | — | — | — | 0 | — | — | — | — |
| Selling/general/admin expenses, other | — | — | — | — | -28.07M | -39.15M | -24.07M | -12.87M | -39.15M | -22.77M | -25.45M | -35.65M | -38.33M | -32.00M | -32.87M | -47.51M | -41.66M | -68.40M | -93.54M |
| Other operating expenses, total | -7.61M | -5.59M | -7.61M | -9.41M | -1.49M | -1.79M | -1.08M | -6.85M | -3.62M | -10.53M | -3.49M | -3.30M | -4.26M | -11.45M | -4.01M | -14.68M | -5.66M | -5.87M | -4.93M |
| Operating income | -82.84M | 13.57M | -14.97M | -375.49M | -57.28M | -93.91M | -110.49M | -123.34M | -135.48M | -168.64M | -134.24M | -127.14M | -152.32M | -240.96M | -236.65M | -394.94M | -219.39M | -154.90M | -217.19M |
| Non-operating income, total | -71.33M | -99.29M | -100.01M | -60.12M | -89.53M | -5.00M | -82.91M | -4.24M | -50.84M | 5.44M | -26.25M | -51.11M | -47.80M | -47.76M | -46.94M | -50.33M | -27.53M | -42.38M | -52.05M |
| Interest expense, net of interest capitalized | -86.73M | -98.76M | -96.09M | -58.92M | -68.96M | -74.39M | -85.46M | -4.55M | -80.57M | -7.39M | -34.88M | -51.65M | -62.38M | -59.28M | -62.79M | -53.91M | -29.73M | -46.89M | -59.14M |
| Interest capitalized | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 15.40M | -535.11K | -3.92M | -1.20M | -20.56M | 69.39M | 2.55M | 500.00K | 224.00K | 16.09M | 12.65M | 14.17M | 13.47M | 12.79M | 16.32M | 3.58M | 2.20M | 4.51M | 7.09M |
| Non-operating interest income | 2.21M | 456.72K | 52.57K | 159.67K | 283.04K | 495.03K | 384.00K | 177.60K | 224.00K | 861.00K | 73.00K | 400.00K | 678.00K | 2.60M | 721.00K | 3.58M | 1.27M | 1.56M | 1.59M |
| Miscellaneous non-operating expense | 13.20M | -991.83K | -3.98M | -1.36M | -20.85M | 68.89M | 2.17M | 322.40K | 0 | 15.23M | 12.58M | 13.77M | 12.80M | 10.19M | 15.60M | 0 | 935.00K | 2.96M | 5.50M |
| Unusual income/expense | — | — | — | — | — | — | — | -192.00K | 29.51M | -3.26M | -4.02M | -13.63M | 1.11M | -1.26M | -465.00K | 0 | 0 | 0 | 0 |
| Pretax income | -154.17M | -85.72M | -114.98M | -435.62M | -146.80M | -98.90M | -193.40M | -127.58M | -186.31M | -163.20M | -160.49M | -178.25M | -200.12M | -288.72M | -283.59M | -445.27M | -246.92M | -197.28M | -269.24M |
| Taxes | 11.75M | 9.02M | 13.28M | 9.34M | 90.12M | 32.08M | 19.02M | 5.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -153.00K |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -142.42M | -76.70M | -101.70M | -426.28M | -56.68M | -66.82M | -174.38M | -121.66M | -186.31M | -163.20M | -160.49M | -178.25M | -200.12M | -288.72M | -283.59M | -445.27M | -246.92M | -197.28M | -269.39M |
| Net income | -142.42M | -76.70M | -101.70M | -426.28M | -56.68M | -66.82M | -174.38M | -121.66M | -186.31M | -163.20M | -160.49M | -178.25M | -200.12M | -288.72M | -283.59M | -445.27M | -246.92M | -197.28M | -269.39M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -142.42M | -76.70M | -101.70M | -426.28M | -56.68M | -66.82M | -174.38M | -121.66M | -186.31M | -163.20M | -160.49M | -178.25M | -200.12M | -288.72M | -283.59M | -445.27M | -246.92M | -197.28M | -269.39M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 8.21M | 119.47M | 92.46M | -280.08M | 41.51M | 2.06M | -13.91M | -57.13M | -98.05M | -123.78M | -91.90M | -85.64M | -108.30M | -194.17M | -185.41M | -331.97M | -153.81M | -87.24M | -150.29M |
| EBIT | -82.84M | 13.57M | -14.97M | -375.49M | -57.28M | -93.91M | -110.49M | -123.34M | -135.48M | -168.64M | -134.24M | -127.14M | -152.32M | -240.96M | -236.65M | -394.94M | -219.39M | -154.90M | -217.19M |
| Total operating expenses | -367.70M | -459.32M | -509.13M | -876.87M | -499.57M | -799.31M | -822.92M | -261.60M | -135.48M | -181.18M | -154.45M | -454.41M | -619.73M | -564.91M | -763.49M | -999.95M | -744.73M | -659.12M | -650.31M |
| Prepaid expenses | 24.13M | 25.30M | 24.11M | 24.04M | 13.71M | 1.91M | 2.33M | 131.00K | 449.00K | 503.00K | 1.41M | 2.93M | 1.34M | 2.40M | 3.95M | 4.92M | 5.18M | 3.76M | 4.73M |
| Deferred income, current | — | — | — | — | — | — | — | — | 1.77M | 1.82M | 1.77M | 17.30M | 55.32M | 58.97M | — | — | — | 168.39M | 147.11M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 164.19M | 155.17M | 141.90M | 132.56M | 42.44M | 9.29M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 120.38M | 76.60M | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | -4.82M | — | — | -727.00K | -2.72M |
| Common dividends paid | -18.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800